1. Combination antiangiogenic tyrosine kinase inhibition and anti‐PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomes. (1st March 2021) Authors: Laccetti, Andrew L.; Garmezy, Benjamin; Xiao, Lianchun; Economides, Minas; Venkatesan, Aradhana; Gao, Jianjun; Jonasch, Eric; Corn, Paul; Zurita‐Saavedra, Amado; Brown, Landon C.; Kao, Chester; Kinsey, Emily N.; Gupta, Rajan T.; Harrison, Michael R.; Armstrong, Andrew J.; George, Daniel J.; Tanni... Journal: Cancer medicine Issue: Volume 10:Number 7(2021) Page Start: 2341 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The Role of Targeted Therapy in the Management of High-Risk Resected Kidney Cancer: What Have We Learned and How Will It Inform Future Adjuvant Trials. Issue 5 (September 2020) Authors: Brown, Landon C.; Zhang, Tian; George, Daniel J. Journal: Cancer journal Issue: Volume 26:Issue 5(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗